Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118299152 | 11829915 | 2 | F | 201511 | 20151225 | 20151213 | 20160101 | EXP | UA-ASTRAZENECA-2015SF22959 | ASTRAZENECA | 50.00 | YR | F | Y | 0.00000 | 20160101 | MD | UA | UA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118299152 | 11829915 | 1 | PS | FORXIGA | DAPAGLIFLOZIN | 1 | Oral | U | 202293 | 10 | MG | TABLET | |||||||
| 118299152 | 11829915 | 2 | SS | FORXIGA | DAPAGLIFLOZIN | 1 | Oral | U | 202293 | 10 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118299152 | 11829915 | 1 | Type 2 diabetes mellitus |
| 118299152 | 11829915 | 2 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118299152 | 11829915 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118299152 | 11829915 | Renal colic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118299152 | 11829915 | 1 | 201509 | 0 |